Fundraising Fox
Libra Therapeutics
4 known investors
Find your way into Libra Therapeutics
Sign up to see every warm intro you have to Libra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Libra Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease. The company's approach aims to restore cellular balance by enhancing the body's natural ability to clear toxic proteins and dysfunctional organelles.
Founders & leadership
Investors · 4
How we know: Dolby Family Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Epidarex Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Libra Therapeutics do?
- Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease. The company's approach aims to restore cellular balance by enhancing the body's natural ability to clear toxic proteins and dysfunctional organelles.
- Who are Libra Therapeutics's investors?
- Libra Therapeutics's investors include Dolby Family Ventures, Epidarex Capital, AMR Action Fund, Boehringer Ingelheim Venture Fund.